SCHEMBL8259846

SCHEMBL8259846

C=C1CCCN1c1ccc2c(c1)CCN(C(=O)OC(C)(C)C)C2

nearest known ligand 0.62

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 2/20 0.62
NR1H2 P55055 1/20 0.58
HDAC1 Q13547 1/20 0.45
TMEM97 Q5BJF2 7/20 0.44
SIGMAR1 Q99720 7/20 0.44
MAPK1 P28482 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
NAMPT P43490 1/20 0.41
ABHD6 Q9BV23 2/20 0.40
DDB1 Q16531 1/20 0.40
CRBN Q96SW2 1/20 0.40
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
ESR1 P03372 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20929548 0.85 NR1H2 (0.65) ESR2NR1H2HDAC1TMEM97SIGMAR1
SCHEMBL3872052 0.83 ESR2 (0.56) ESR2NR1H2HDAC1TMEM97SIGMAR1
SCHEMBL25407569 0.81 ESR2 (0.67) ESR2NR1H2HDAC1TMEM97SIGMAR1
SCHEMBL30593262 0.81 ESR2 (0.67) ESR2NR1H2HDAC1TMEM97SIGMAR1
SCHEMBL26845053 0.79 ESR2 (0.61) ESR2NR1H2HDAC1TMEM97SIGMAR1
SCHEMBL31164748 0.79 ESR2 (0.61) ESR2NR1H2HDAC1TMEM97SIGMAR1
SCHEMBL61143 0.78 NR1H2 (0.90) ESR2NR1H2HDAC1MAPK1NPC1
SCHEMBL29377835 0.78 NR1H2 (0.90) ESR2NR1H2HDAC1MAPK1NPC1
SCHEMBL20929489 0.78 NR1H2 (0.61) ESR2NR1H2HDAC1TMEM97SIGMAR1
SCHEMBL4171919 0.78 ESR2 (0.58) ESR2NR1H2HDAC1TMEM97SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006108709-A1 3-SULFONYLAMINO-PYRROLIDINE-2-ONE DERIVATIVES AS FACTOR XA INHIBITORS GLAXO GROUP LIMITED (GB) 2006-10-19 WO disclosed